Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stroke Prevention in Patients With Atrial Fibrillation”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Not applicableStudy completedNCT02960880
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Who this might be right for
Atrial Fibrillation
Bayer 99,999
Not applicableStudy completedNCT04435769
What this trial is testing

Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment

Who this might be right for
Atrial Fibrillation
Pfizer 109
Not applicableStudy completedNCT01090362
What this trial is testing

Global Anticoagulant Registry in the Field

Who this might be right for
Atrial Fibrillation
Thrombosis Research Institute 57,250
Not applicableStudy completedNCT02714855
What this trial is testing

Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 2,081
Not applicableStudy completedNCT03847181
What this trial is testing

Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice

Who this might be right for
Atrial Fibrillation
Bayer 45,164
Not applicableStudy completedNCT03374540
What this trial is testing

Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

Who this might be right for
Nonvalvular Atrial Fibrillation
Bayer 78,517
Testing effectiveness (Phase 2)Study completedNCT01227629
What this trial is testing

PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 502
Not applicableStudy completedNCT02784717
What this trial is testing

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Who this might be right for
Stroke
Bayer 3,055
Post-approval studies (Phase 4)Looking for participantsNCT03968393
What this trial is testing

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

Who this might be right for
StrokeAtrial Fibrillation
Population Health Research Institute 2,270
Not applicableStudy completedNCT02262676
What this trial is testing

Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain

Who this might be right for
Atrial Fibrillation
Bayer 2,251
Testing effectiveness (Phase 2)Study completedNCT00645853
What this trial is testing

Long-term Safety in Atrial Fibrillation Patients

Who this might be right for
Persistent or Permanent Nonvalvular Atrial Fibrillation
AstraZeneca 523
Post-approval studies (Phase 4)Study completedNCT01493557
What this trial is testing

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,067
Not applicableUnknownNCT03108872
What this trial is testing

Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Sejong General Hospital 300
Not applicableStudy completedNCT01805531
What this trial is testing

Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication

Who this might be right for
Atrial Fibrillation
Bayer 411
Not applicableStudy completedNCT03563937
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon

Who this might be right for
Atrial Fibrillation
Bayer 64,920
Not applicableStudy completedNCT02470767
What this trial is testing

An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres

Who this might be right for
StrokePrevention and ControlAtrial Fibrillation
Bayer 792
Not applicableStudy completedNCT02640222
What this trial is testing

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 321,501
Not applicableLooking for participantsNCT07575867
What this trial is testing

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

Who this might be right for
Atrial FibrillationStroke Prevention in Patients With Atrial FibrillationLeft Atrial Appendage Closure+4 more
National Medical Research Center for Therapy and Preventive Medicine 464
Not applicableLooking for participantsNCT07349121
What this trial is testing

OPTION-EMEA Clinical Trial

Who this might be right for
Atrial Fibrillation (AF)Stroke Prevention in Patients With Atrial FibrillationLeft Atrial Appendage Closure+3 more
Boston Scientific Corporation 500
Not applicableStudy completedNCT03284762
What this trial is testing

Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Bayer 1,216
Next Page